202
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Stereotactic radiosurgery to treat presumed Rathke's cleft cysts

, , , , &
Pages 684-691 | Received 04 Jan 2012, Accepted 27 Feb 2012, Published online: 30 Mar 2012
 

Abstract

Objective. Stereotactic radiosurgery (SRS) has been developed as a clinical treatment method for certain brain tumours that does not need craniotomy. As a more accurate radiation technique, SRS can deliver a relatively large dose of stereotactic radiation to a conformal target with less normal brain tissue irradiated in a single treatment. The aim of this study is to evaluate the therapeutic effects of SRS for Rathke's cleft cysts (RCCs). Methods. SRS was performed using a rotating gamma ray unit in seven selected patients with symptomatic RCCs diagnosed upon typical MR imaging combined with clinical manifestation. The patients included one male and six females with an age range from 25 to 63 years (mean 43.4 years). Five patients presented with headache, three with menstrual disorder or infertility and one with vision impairment. No other endocrine dysfunction was observed. SRS was performed in the patients with a central dose varied from 22.6 to 40 Gy (mean 32.5 Gy) and a peripheral dose from 9 to 20 Gy (mean 13.4 Gy). Results. The patients were followed up for 11–105 months (mean 38.6 months) after SRS. All symptoms that presented before treatment were relieved within 3–6 months post-SRS and no endocrine dysfunction was developed during the follow-up period. MR imaging demonstrated that the RCCs were completely disappeared in five cases and significantly shrunken in the other two cases. No recurrence was observed in any cases during the follow-up. Conclusion. This study demonstrates that SRS can treat RCCs effectively without evident side effects.

Acknowledgements

The authors would like to thank Dr. Xiaoping Zhou, M.D., Ph.D. (Department of pathology, Ohio state university, Columbus, USA), for critical review of this paper.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.